Short Interest in Phibro Animal Health Co. (NASDAQ:PAHC) Drops By 17.5%

Phibro Animal Health Co. (NASDAQ:PAHCGet Free Report) was the recipient of a large drop in short interest in March. As of March 31st, there was short interest totalling 706,200 shares, a drop of 17.5% from the March 15th total of 855,800 shares. Based on an average daily volume of 145,000 shares, the days-to-cover ratio is presently 4.9 days. Approximately 3.5% of the shares of the stock are sold short.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of PAHC. Swiss National Bank lifted its stake in shares of Phibro Animal Health by 7.6% in the 1st quarter. Swiss National Bank now owns 48,100 shares of the company’s stock valued at $960,000 after acquiring an additional 3,400 shares during the last quarter. Raymond James & Associates lifted its stake in shares of Phibro Animal Health by 7.3% in the 1st quarter. Raymond James & Associates now owns 77,075 shares of the company’s stock valued at $1,538,000 after acquiring an additional 5,274 shares during the last quarter. Citigroup Inc. lifted its stake in shares of Phibro Animal Health by 12.2% in the 1st quarter. Citigroup Inc. now owns 27,442 shares of the company’s stock valued at $547,000 after acquiring an additional 2,977 shares during the last quarter. MetLife Investment Management LLC lifted its stake in shares of Phibro Animal Health by 51.1% in the 1st quarter. MetLife Investment Management LLC now owns 15,103 shares of the company’s stock valued at $301,000 after acquiring an additional 5,110 shares during the last quarter. Finally, Rhumbline Advisers lifted its stake in shares of Phibro Animal Health by 6.6% in the 1st quarter. Rhumbline Advisers now owns 62,216 shares of the company’s stock valued at $1,241,000 after acquiring an additional 3,877 shares during the last quarter. 99.34% of the stock is currently owned by institutional investors.

Phibro Animal Health Trading Up 0.2 %

Shares of PAHC stock opened at $13.11 on Monday. The stock’s fifty day moving average price is $12.54 and its two-hundred day moving average price is $11.73. The company has a market cap of $530.96 million, a PE ratio of 36.42, a P/E/G ratio of 4.85 and a beta of 0.75. Phibro Animal Health has a fifty-two week low of $9.40 and a fifty-two week high of $15.98. The company has a debt-to-equity ratio of 1.66, a quick ratio of 1.60 and a current ratio of 3.12.

Phibro Animal Health (NASDAQ:PAHCGet Free Report) last issued its earnings results on Wednesday, February 7th. The company reported $0.33 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.06. The firm had revenue of $249.90 million for the quarter, compared to the consensus estimate of $242.91 million. Phibro Animal Health had a return on equity of 16.67% and a net margin of 1.51%. Equities analysts predict that Phibro Animal Health will post 1.12 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Stockholders of record on Wednesday, March 6th were paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.66%. The ex-dividend date was Tuesday, March 5th. Phibro Animal Health’s payout ratio is 133.33%.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Tuesday, April 9th.

View Our Latest Analysis on PAHC

About Phibro Animal Health

(Get Free Report)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

Featured Stories

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.